Exciting News! BioLabs has partnered with Eisai US to launch a new Biolabs site in MA! Eisai Innovation Center Biolabs will be located at the Eisai Center for Genetics Guided Dementia Discovery (G2D2) facility and will host neurology-focused start-ups. prn.to/3tlriDT

What questions you have questions about #immunotherapy? Comment below with any questions you have about immunotherapy in brain tumor research, and we’ll answer on Friday, November 26! #Informedin30

Our results illustrate the power of single-cell technology to reveal intratumor heterogeneity in clinical tissues.

An extraordinary experience to sit next to Carl June and imagine a future where CRISPR-based therapies have 20,000 patients treated - as CAR-T already has! Well, that future does not have to be a decade away. It could be sooner. I'm serious: tinyurl.com/bddb3nt8